Perspektywy optymalizacji terapii komórkowej z użyciem komórek macierzystych dla regeneracji serca mięśniowego
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2017, Vol 71, Issue
Abstract
There is a variety of mechanisms(s) factor(s) that may influence stem cell therapies for heart regeneration. Among the best candidates for stem cell source are: mesenchymal stem cells (also those isolated from adipose tissue), cardiac cell progenitors (CPC) and descendants of iPSC cells. iPSC/s can be potentially beneficial although their pluripotent induction has been still in question due to: low propagation efficacy, danger of genomic integration/instability, biological risk of current vector system teratoma formation etc. which have been discussed in this review. Optimization protocols are required in order to enhance stem cells resistance to pathological conditions that they may encounter in pathological organ and to increase their retention. Combination between gene transfer and stem cell therapy is now more often used in pre-clinical studies with the prospect of subsequent clinical trials. Complementary substances have been contemplated to support stem cell viability (mainly anti-inflammatory and anti- apoptotic agents), which have been tested in animal models with promising results. Integration of nanotechnology both for efficient stem cell imaging as well as with the aim to provide cell supporting scaffolds seem to be inevitable for further development of cellular therapies. The whole organ (heart) reconstruction as well as biodegradable scaffolds and scaffold-free cell sheets have been also outlined.
Authors and Affiliations
Paulina Gapska, Maciej Kurpisz
Sklerostyna i przewlekła choroba nerek
Przewlekła choroba nerek (PChN) prowadzi do zaburzeń mineralnych i kostnych, zwiększając częstość złamań, powikłań sercowo-naczyniowych i śmiertelność. Szlak sygnałowy Wnt/β-katenina odgrywa istotną rolę w rozwoju oraz p...
Dipeptidyl peptidase IV: An attractive target for the development of effective diagnostic and therapeutic strategies
DPP IV is a peptidase with a catalytic activity and the ability to bind extracellular matrix proteins. It participates in the metabolism of glucose, gastrointestinal motility, the regulation of appetite and affects the f...
Poly(ADP-ribose) polymerase (PARP) inhibitors in BRCA1/2 cancer therapy
A majority of currently used anticancer drugs belong to a group of chemical agents that damage DNA. The efficiency of the treatment is limited by effective DNA repair systems functioning in cancer cells. Many chemothera...
Odkrycie neuromedyny U i jej rola w centralnej regulacji homeostazy energetycznej
Neuromedyna U (NMU) jest neuropeptydem o wysoce konserwatywnej strukturze, a jej receptory (NMUR1 i NMUR2) należą do rodziny receptorów związanych z białkami G (GPCR) zaliczanych do grupy tzw. receptorów sierocych. Akty...
Cancer cells and oxidative stress
Reactive oxygen species (ROS) formation are a constant element of a cell’s oxygen metabolism. They are its normal products and in physiological concentrations they play important roles in a variety of cell processes. Dis...